InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (36 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
36
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Goldsmith Mark A, Executive. Director active across 2 companies, notably Revolution Medicines, Inc.. In total, 65 filings have been published. Breakdown: 0 buy · 36 sells. Total volume traded: €36.5m. Activity tracked since 17 June 2021. The latest transaction was disclosed on 21 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Goldsmith Mark A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
80,000 shares@ US$4.73Common StockSEC:0001610717-26-000387:0
5,128 shares@ US$207.233Common StockSEC:0001610717-26-000387:1
24,917 shares@ US$208.3697Common StockSEC:0001610717-26-000387:2
35,938 shares@ US$209.2615Common StockSEC:0001610717-26-000387:3
3,813 shares@ US$210.2466Common StockSEC:0001610717-26-000387:4
6,583 shares@ US$211.3331Common StockSEC:0001610717-26-000387:5
3,621 shares@ US$212.0776Common StockSEC:0001610717-26-000387:6
190 shares@ US$207.2454Common StockSEC:0001610717-26-000387:7
951 shares@ US$208.3648Common StockSEC:0001610717-26-000387:8
1,351 shares@ US$209.2812Common StockSEC:0001610717-26-000387:9
136 shares@ US$210.4017Common StockSEC:0001610717-26-000387:10
245 shares@ US$211.4651Common StockSEC:0001610717-26-000387:11
127 shares@ US$212.0635Common StockSEC:0001610717-26-000387:12
177 shares@ US$207.2515Common StockSEC:0001610717-26-000387:13
937 shares@ US$208.3609Common StockSEC:0001610717-26-000387:14
1,405 shares@ US$209.2664Common StockSEC:0001610717-26-000387:15
126 shares@ US$210.403Common StockSEC:0001610717-26-000387:16
229 shares@ US$211.4648Common StockSEC:0001610717-26-000387:17
126 shares@ US$212.0641Common StockSEC:0001610717-26-000387:18
10,020 sharesCommon StockSEC:0001610717-26-000246:0
23,244 shares@ US$4.090.4% of flowCommon StockSEC:0001610717-26-000146:0
96,756 shares@ US$4.732.0% of flowCommon StockSEC:0001610717-26-000146:1
120,000 shares@ US$150.087480.0% of flowCommon StockSEC:0001610717-26-000146:2
12,871 shares@ US$99.48045.4% of flowCommon StockSEC:0001610717-26-000130:0
57,100 shares0Common StockSEC:0001610717-26-000082:0
25 of 65 declarations
About Goldsmith Mark A
GOLDSMITH MARK A is an insider linked to Revolution Medicines, Inc. and, according to the data provided, also a director at Constellation Pharmaceuticals INC. Across 46 filings in total, the sampled recent filings from 2021-06-22 to 2026-06-18 show 0 in buys and 21139829 in sells, with the modal transaction nature listed as option exercise.
